Description
Description: Nitib contains ibrutinib, a Bruton’s tyrosine kinase inhibitor used in the treatment of specific types of blood cancers.
Contents: Each capsule contains 140mg of ibrutinib.
Uses:
- Treatment of mantle cell lymphoma (MCL).
- Treatment of chronic lymphocytic leukemia (CLL).
- Also indicated for Waldenström’s macroglobulinemia.
How it Works: Ibrutinib inhibits Bruton’s tyrosine kinase, which is crucial for the survival and proliferation of B-cell malignancies. By blocking this enzyme, it helps to induce apoptosis in cancer cells and reduce tumor growth.
Directions for Use: Taken orally once daily, with or without food. It is important to follow the prescribed dosing schedule and not to crush or chew the capsules.
Side Effects:
- Diarrhea
- Fatigue
- Nausea
- Risk of bleeding or bruising
- Infections due to low white blood cell counts
Precautions:
- Regular monitoring of blood counts is necessary to detect any abnormalities.
- Patients should be aware of signs of bleeding and report them to their healthcare provider.
- Not recommended during pregnancy or breastfeeding due to potential risks to the fetus or infant.
There are no reviews yet.